JORGE E CORTES to Drug Substitution
This is a "connection" page, showing publications JORGE E CORTES has written about Drug Substitution.
Connection Strength
0.678
-
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study. Clin Lymphoma Myeloma Leuk. 2016 05; 16(5):286-96.
Score: 0.521
-
Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY. Am J Hematol. 2019 01; 94(1):46-54.
Score: 0.157